Skip to content

Pulse Biosciences, Inc. PLSE Free cash flow yield

Free cash flow yield at other companies

Abbott logo
AbbottABT
4.1%+1.2pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
3%-2.1pp
Boston Scientific logo
Boston ScientificBSX
3.7%+1.7pp
Medtronic logo
MedtronicMDT
5.2%+0.4pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.4%+2.5pp
ITG
Integer HoldingsITGR
3.3%+0.6pp

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s free cash flow yield?
Pulse Biosciences, Inc. (PLSE) reported free cash flow yield of -3.8% in Q1 2026.
How has Pulse Biosciences, Inc.'s free cash flow yield changed year-over-year?
Pulse Biosciences, Inc.'s free cash flow yield increased by 0.4% year-over-year, from -3.8% to -3.8%.
What is the long-term trend for Pulse Biosciences, Inc.'s free cash flow yield?
Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s free cash flow yield has grown at a 0.3% compound annual growth rate (CAGR), from -5.8% to -5.9%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.